INCY
INCY
NASDAQ · Biotechnology

Incyte Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$119.29
-2.60 (-2.13%)
Analyst Consensus
Hold
35
Analysts
Very High
Coverage
Buy 19 54%
Hold 16 46%
Sell 0 0%
Price Target
Analyst Price Target +73.4% upside
Low Target $125.25
Average Target $206.81
High Target $260.19
Current Price $119.29
Current
$119.29
Target
$206.81
$125.25 $206.81 avg $260.19
Scenario Analysis
Bear Case
$125.25
5.0%
Low target
Base Case
$206.81
+73.4%
Avg target
Bull Case
$260.19
+118.1%
High target
Risk/Reward
23.6x
Highly favorable
Price in Context
52-Week High
$132.60
-10.0% from high
52-Week Low
$89.25
+33.7% from low
50-Day SMA
$119.57
-0.2% vs SMA
200-Day SMA
$108.53
+9.9% vs SMA
RSI (14)
57.7
Neutral
Target vs 52W High
$206.81
+56.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.4%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.8%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +113.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -20.3%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -42.1%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.6%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -54.5%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -40.3%